Table 3. Cumulative incidence of clinical outcomes according to CYP2C19 variant in elderly patients.

	NM or IM	PM
	(n=694)	(n=117)
Primary endpoint	30 (4.4%)	10 (8.7%)
Any Death	25 (3.7%)	9 (7.8%)
Cardiac Death	17 (2.5%)	7 (6.1%)
Myocardial infarction	7 (1.0%)	2 (1.7%)
Stent thrombosis	7 (1.0%)	3 (2.6%)
Target lesion revascularization	32 (4.6%)	6 (5.1%)
Major bleeding	38 (5.5%)	8 (7.1%)

Values are expressed as the number of patients (%: cumulative incidence). The primary endpoint was a composite of myocardial infarction and death.